Source: International Congress 2015 – Science and biomarkers in TB
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Allison Wolf (New York, United States of America), Allison Wolf, Max O’Donnell, Paras Jain, Vanisha Munsamy, Farina Karim, Michelle Larsen, Alexander Pym, William R. Jacobs. Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods. Eur Respir J 2015; 46: Suppl. 59, 3489

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region Source: Annual Congress 2010 - Global tuberculosis control Year: 2010 Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Identification of novel tuberculosis diagnostic biomarkers in plasma and saliva Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Biomarkers and VAP: results and perspectives Source: Eur Respir Mon 2011; 53: 24-35 Year: 2011 Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Rapid detection of mycobacterial growth in in vitro cultures by VOC analysis Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Enhanced diagnosis of tuberculosis using a dual gene target detection approach Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Rapid monitoring of tuberculosis treatment response: A multi-centre study Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment Year: 2016 Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019 Year: 2020 Characteristics of the new cases of the tuberculosis according to the method of screening Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Tuberculosis: update on new diagnostic methods and treatment approach Source: Annual Congress 2007 - Infections year in review Year: 2007